|
Volumn 80, Issue 12, 1997, Pages 777-783
|
Phase II Study : Concurrent Chemo-Radiotherapy in Advanced Nasopharyngeal Carcinoma
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MUCOSA INFLAMMATION;
NASOPHARYNX CARCINOMA;
NAUSEA;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
VOMITING;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
NASOPHARYNGEAL NEOPLASMS;
PROSPECTIVE STUDIES;
|
EID: 0031435715
PISSN: 01252208
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (8)
|